0.58
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Market Closed
Low
0.50
High
1.95
Best deals to access real time data! |
|
Canna Trader Pro
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Numinus Wellness Inc | NUMI | TSX Venture | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 0.58 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.58 | 0.58 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.58 | CAD |
Period:
Draw Mode:
Numinus Wellness Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 134.03M | 190.79M | 190.79M | $ 1.51M | $ 0.00 | -0.11 | -6.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 1.01M | $ - | - | 0.00 | - |
Numinus Wellness News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NUMI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 3 Months | 0.70 | 0.79 | 0.50 | 0.6378369 | 414,445 | -0.12 | -17.14% |
| 6 Months | 1.00 | 1.04 | 0.50 | 0.7739809 | 381,540 | -0.42 | -42.0% |
| 1 Year | 1.39 | 1.95 | 0.50 | 1.14 | 1,037,223 | -0.81 | -58.27% |
| 3 Years | 1.00 | 2.45 | 0.185 | 1.04 | 1,428,121 | -0.42 | -42.0% |
| 5 Years | 1.00 | 2.45 | 0.185 | 1.04 | 1,428,121 | -0.42 | -42.0% |
Numinus Wellness Description
| Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its own laboratory and research & development processes. |